ArticleCancer science2018

Isocitrate dehydrogenase 1 mutation sensitizes intrahepatic cholangiocarcinoma to the BET inhibitor JQ1.

Hiroaki Fujiwara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.